73 related articles for article (PubMed ID: 8914421)
1. [Hereditary background and natural history in glucose-intolerance group].
Ito C
Nihon Rinsho; 1996 Oct; 54(10):2636-42. PubMed ID: 8914421
[TBL] [Abstract][Full Text] [Related]
2. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
Mohan V; Shanthirani CS; Deepa R
J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
[TBL] [Abstract][Full Text] [Related]
3. Hyper insulinism and decreased insulin sensitivity in nonobese healthy offspring of conjugal diabetic parents and individuals with IGT and NIDDM.
Rao CA; Snehalatha C
Indian J Physiol Pharmacol; 1996 Apr; 40(2):139-44. PubMed ID: 9062808
[TBL] [Abstract][Full Text] [Related]
4. Progression to impaired glucose metabolism in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran.
Janghorbani M; Amini M
Diabetes Metab Res Rev; 2009 Nov; 25(8):748-55. PubMed ID: 19862775
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
Shalitin S; Abrahami M; Lilos P; Phillip M
Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
[TBL] [Abstract][Full Text] [Related]
6. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of non-insulin-dependent diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec.
Delisle HF; Ekoé JM
CMAJ; 1993 Jan; 148(1):41-7. PubMed ID: 8439889
[TBL] [Abstract][Full Text] [Related]
9. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.
Henriksen JE; Alford F; Ward GM; Beck-Nielsen H
Diabetologia; 1997 Dec; 40(12):1439-48. PubMed ID: 9447952
[TBL] [Abstract][Full Text] [Related]
10. Age-specific prevalence and risk associations for impaired glucose tolerance in urban southern Indian population.
Snehalatha C; Ramchandran A; Kapur A; Vijay V
J Assoc Physicians India; 2003 Aug; 51():766-9. PubMed ID: 14651135
[TBL] [Abstract][Full Text] [Related]
11. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
Ko GT; Cockram CS; Chan JC
J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
[TBL] [Abstract][Full Text] [Related]
12. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise.
Eriksson KF; Lindgärde F
Diabetologia; 1998 Sep; 41(9):1010-6. PubMed ID: 9754818
[TBL] [Abstract][Full Text] [Related]
13. [Dyslipidemia and hyperinsulinemia in normoglycemic-obese relatives of patients with non-insulin dependent diabetes mellitus].
Florez H; Valbuena H; Ryder E; Rincón E; Campos G; Castillo S; González J; Fernández V; Raleigh X; Gómez ME
Invest Clin; 1995 Sep; 36(3):131-47. PubMed ID: 7548306
[TBL] [Abstract][Full Text] [Related]
14. [Insulin sensitivity and beta cell function in different glucose tolerance status].
Gómez-García A; Magaña-Garns P; Ruiz-García J; Alvarez-Aguilar C
Invest Clin; 2006 Jun; 47(2):155-66. PubMed ID: 16886777
[TBL] [Abstract][Full Text] [Related]
15. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
[TBL] [Abstract][Full Text] [Related]
16. Metabolic characteristics of glucose intolerance: the critical role of obesity.
Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
[TBL] [Abstract][Full Text] [Related]
17. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
[TBL] [Abstract][Full Text] [Related]
18. The clinical implications of impaired glucose tolerance.
Alberti KG
Diabet Med; 1996 Nov; 13(11):927-37. PubMed ID: 8946150
[TBL] [Abstract][Full Text] [Related]
19. New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors.
Heine RJ; Nijpels G; Mooy JM
Diabet Med; 1996; 13(3 Suppl 2):S12-4. PubMed ID: 8689855
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
